Trupanion (NASDAQ:TRUP) Upgraded to Strong-Buy at Zacks Research

Zacks Research upgraded shares of Trupanion (NASDAQ:TRUP) from a hold rating to a strong-buy rating in a report issued on Tuesday morning,Zacks.com reports.

A number of other analysts have also weighed in on the stock. Weiss Ratings restated a “sell (d+)” rating on shares of Trupanion in a research note on Monday, December 29th. Wall Street Zen downgraded shares of Trupanion from a “buy” rating to a “hold” rating in a research report on Saturday, December 6th. Piper Sandler reduced their price objective on shares of Trupanion from $67.00 to $60.00 and set an “overweight” rating on the stock in a report on Friday, December 19th. Finally, Stifel Nicolaus lowered their target price on shares of Trupanion from $45.00 to $42.00 and set a “hold” rating for the company in a research note on Tuesday, November 18th. One research analyst has rated the stock with a Strong Buy rating, two have given a Buy rating, two have issued a Hold rating and one has assigned a Sell rating to the company. According to MarketBeat, the company presently has an average rating of “Moderate Buy” and an average price target of $52.25.

Trupanion Stock Down 2.0%

Shares of NASDAQ TRUP opened at $35.78 on Tuesday. The stock has a market cap of $1.55 billion, a P/E ratio of 99.39 and a beta of 1.58. The business’s fifty day simple moving average is $37.41 and its 200-day simple moving average is $43.67. Trupanion has a 12-month low of $31.00 and a 12-month high of $57.88. The company has a current ratio of 1.71, a quick ratio of 1.71 and a debt-to-equity ratio of 0.31.

Trupanion (NASDAQ:TRUP) last released its earnings results on Thursday, November 6th. The financial services provider reported $0.13 EPS for the quarter, missing the consensus estimate of $0.89 by ($0.76). The company had revenue of $366.92 million for the quarter, compared to analyst estimates of $361.58 million. Trupanion had a return on equity of 4.48% and a net margin of 1.10%.The company’s revenue for the quarter was up 12.0% compared to the same quarter last year. During the same period in the previous year, the firm earned $0.03 earnings per share. As a group, equities analysts predict that Trupanion will post 0.13 EPS for the current fiscal year.

Insider Activity

In related news, CFO Fawwad Qureshi sold 6,202 shares of Trupanion stock in a transaction on Wednesday, November 26th. The shares were sold at an average price of $35.45, for a total transaction of $219,860.90. The sale was disclosed in a document filed with the SEC, which can be accessed through this link. Also, CEO Margaret Tooth sold 9,803 shares of the business’s stock in a transaction on Tuesday, November 25th. The shares were sold at an average price of $35.31, for a total transaction of $346,143.93. Following the completion of the sale, the chief executive officer directly owned 151,899 shares of the company’s stock, valued at approximately $5,363,553.69. This trade represents a 6.06% decrease in their ownership of the stock. Additional details regarding this sale are available in the official SEC disclosure. In the last quarter, insiders sold 41,307 shares of company stock worth $1,556,742. Corporate insiders own 5.42% of the company’s stock.

Institutional Trading of Trupanion

A number of large investors have recently made changes to their positions in TRUP. Federated Hermes Inc. acquired a new position in Trupanion during the third quarter worth approximately $33,000. Pilgrim Partners Asia Pte Ltd purchased a new position in shares of Trupanion during the third quarter worth approximately $39,000. Nisa Investment Advisors LLC increased its holdings in shares of Trupanion by 44.1% in the 2nd quarter. Nisa Investment Advisors LLC now owns 980 shares of the financial services provider’s stock valued at $54,000 after acquiring an additional 300 shares during the period. Kelleher Financial Advisors acquired a new position in shares of Trupanion in the 3rd quarter valued at $74,000. Finally, GAMMA Investing LLC raised its position in Trupanion by 30.1% in the 2nd quarter. GAMMA Investing LLC now owns 2,133 shares of the financial services provider’s stock valued at $118,000 after purchasing an additional 494 shares during the last quarter.

Trupanion Company Profile

Trupanion, Inc is a pet medical insurance company that provides comprehensive insurance coverage for cats and dogs. The company’s core offering is a single, customizable medical policy designed to cover veterinary diagnostic tests, surgeries, hospital stays and congenital or hereditary conditions. Trupanion seeks to streamline the claims process by offering direct payment options to participating veterinarians, reducing the need for upfront payments by pet owners.

Founded in 1999 by Darryl Rawlings and headquartered in Seattle, Washington, Trupanion began operations in the early 2000s and has grown its presence through both digital channels and partnerships with veterinary hospitals.